Cancer Research

Y. Haupt, R. Maya, A. Kazaz, M. Oren, "Mdm2 promotes the rapid degradation of p53," Nature, 387:296-99, 1997. (Cited in more than 230 papers since publication) Comments by Moshe Oren, a professor in the Department of Molecular Cell Biology at the Weizmann Institute of Science, Rehovot, Israel M.H.G. Kubbutat, S.N. Jones, K.H. Vousden, "Regulation of p53 stability by Mdm2," Nature, 387:299-303, 1997. (Cited in more than 215 papers since publication) Comments by Karen H. Vousden, interim dire

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Y. Haupt, R. Maya, A. Kazaz, M. Oren, "Mdm2 promotes the rapid degradation of p53," Nature, 387:296-99, 1997. (Cited in more than 230 papers since publication)

Comments by Moshe Oren, a professor in the Department of Molecular Cell Biology at the Weizmann Institute of Science, Rehovot, Israel

M.H.G. Kubbutat, S.N. Jones, K.H. Vousden, "Regulation of p53 stability by Mdm2," Nature, 387:299-303, 1997. (Cited in more than 215 papers since publication)

Comments by Karen H. Vousden, interim director of the Advanced Bioscience Laboratories Basic Research Program at the Frederick Cancer Research and Development Center in Frederick, Md.

In trying to publish their findings on a novel aspect of the relationship between the protein Mdm2 (mouse double minute 2, after the first source from which the gene was cloned) and the frequently mutated tumor suppressor protein p53, the authors of these two papers faced a good deal of skepticism. Fortunately, the two ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies